Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software With Leading Provider of Mass Spectrometry Systems
Is Bruker Corporation (NASDAQ:BRKR) A High Quality Stock To Own?
Goldman's 'Goldilocks' Mid-cap Picks That Trade at Reasonable Valuations
Here's Why Bruker Corporation (BRKR) Fell in Q2
Jefferies Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $85
Jefferies analyst Tycho Peterson maintains $Bruker Corp(BRKR.US)$ with a buy rating, and maintains the target price at $85.According to TipRanks data, the analyst has a success rate of 57.9% and a
Biognosys Announces Commercial Availability of NULISA Proteomics Assay Services for Biomarker Research